D'Ursi Pasqualina, Chiappori Federica, Merelli Ivan, Cozzi Paolo, Rovida Ermanna, Milanesi Luciano
CNR-Institute for Biomedical Technologies, Via Fratelli Cervi 93, 20090 Segrate (MI), Italy.
Biochem Biophys Res Commun. 2009 Jun 12;383(4):445-9. doi: 10.1016/j.bbrc.2009.04.030. Epub 2009 Apr 14.
The H5N1 virus neuraminidase structure was solved in two different conformations depending on the inhibitor concentration. In the absence of oseltamivir or at a low concentration, the neuraminidase structure assumes an open form that closes at a high oseltamivir concentration due to the shift of the so-called 150-loop near the active site. Although the close conformation is similar to all the other structurally known neuraminidase types, it doesn't appear to be the most likely physiological condition for N1. To investigate the specific ligand binding properties of the open form, we screened by docking simulation, a large dataset of ligands and compared the results with closed form. The virtual screening procedure was implemented in a docking pipeline that also performs a step-by-step, target specific, filtering approach for data reduction. The selected ligands display binding ability involving multiple sites of interaction including the active site and an adjacent cavity made available by the 150-loop shift. Two ligands are especially interesting and are proposed as substituents to design oseltamivir derivatives specifically suited for the open conformation.
H5N1病毒神经氨酸酶的结构根据抑制剂浓度呈现出两种不同的构象。在没有奥司他韦或低浓度时,神经氨酸酶结构呈现开放形式,而在高浓度奥司他韦情况下,由于活性位点附近所谓的150环的移动,结构会闭合。尽管闭合构象与所有其他已知结构的神经氨酸酶类型相似,但它似乎并非N1最可能的生理状态。为了研究开放形式的特定配体结合特性,我们通过对接模拟筛选了大量配体数据集,并将结果与闭合形式进行比较。虚拟筛选程序在一个对接流程中实施,该流程还执行逐步的、针对目标的过滤方法以减少数据量。所选配体显示出涉及多个相互作用位点的结合能力,包括活性位点以及由150环移动形成的相邻腔。有两种配体特别有趣,被提议作为取代基来设计特别适合开放构象的奥司他韦衍生物。